Mr. Toan is a Senior Associate with over 7 years of professional experience. He is a core member of the firm’s Pharmaceutical & Healthcare practice group and possesses extensive expertise across various practice areas, including M&A, Corporate & Foreign Investment, and Compliance & ABAC. He also has experience representing clients in the resolution of commercial disputes.
• Vietnam Bar Federation
• HCMC Bar Association
• International Bar Association
LL.B (University of Economics and Law – Vietnam National University Ho Chi Minh City)
Vietnamese
English
M&A
• Assisted Mitsui Matsushima Holdings Co., Ltd. in conducting legal due diligence on the Vietnamese subsidiary manufacturing cotton swabs and cotton pads as part of its acquisition of shares in Sanyo Co., Ltd., the Japanese holding company.
• Advised Sanofi on the Vietnamese law aspects of its divestiture of the sale operations for the drug Alpha Choay in Vietnam and Cambodia to Lotus Pharmaceutical.
• Advised private equity fund Eastbridge Partners on acquisition of a strategic interest in USM Healthcare Medical Devices Factory JSC, the first coronary stent manufacturer in Vietnam. Also advised EastBridge Partners on the divestment of its entire shareholding in USM in May 2026, successfully concluding a productive investment spanning roughly 4.5 year.
• Advised Vietnam - Singapore Smart Energy Solutions (VSSES) on the acquisition of approximately 70 rooftop solar power projects in Vietnam.
• Advised BASF on the Vietnamese law aspects of the global sale of its construction chemicals business to global private equity firm Lone Star.
Pharmaceutical & Healthcare
• Seconded to STADA Pymepharco as Head of Legal & Compliance during the transition period.
• Advised Roche Group on a retainer basis on all matters relating to daily operations of Vietnamese pharmaceutical subsidiary and in vitro diagnostic solutions subsidiary.
• Advised Boehiringer on compliance and licensing matters of Vietnamese pharmaceutical subsidiary.
• Advised Dr. Reddy’s Laboratories, STADA Pymepharco, Aikya Distribution and Boston Scientific on feasibility of local business models.
• Assisted GlaxoSmithKline (GSK) in conducting a proactive review of its Vietnamese subsidiary’s end-to-end processes for vaccine and pharmaceutical product authorizations/variations.
Litigation & ADR
• Advised and assisted a Singaporean logistics corporation in taking legal actions to recover the investment capital into its Vietnamese subsidiary of more than USD 300,000 which was misappropriated by a local license service provider.
• Assisted a Singaporean chemical corporation in defending its Vietnamese subsidiary against a key distributor’s claim in court concerning alleged unfulfilled promotional incentive promises made by a former sales lead. The client successfully refuted the claim, and the distributor subsequently withdrew its claim.
• Assisted a Japanese-owned leading truck manufacturer in Court proceedings to defend against damages claim filed by the insurer of its customer following a fire incident involving the client’s truck. The client successfully reached an out-of-court settlement.
• Assisted a Japanese-owned logistics service provider in two parallel arbitration proceedings at VIAC concerning disputes with one of Vietnam’s largest conglomerates over two transportation service agreements. The client successfully reached an out-of-arbitration settlement.
• Assisted a Cayman Islands investment company in Court proceedings for recognition and enforcement in Vietnam of SIAC award over a loan contractual dispute of over US$ 1 million.
• 2022, (with Dr Nguyen Anh Tuan), Vietnam Chapter, Lexology Getting The Deal Through – Pharma & Medical Device Regulations 2022: Vietnam Chapter;
• 2020, (with Tran Hoang My), In-House Community – Dealing with Covid-19 induced delays to real estate investment projects
